Inovio Pharmaceuticals, Inc.
INO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001055726
No open-market purchases or sales by Inovio Pharmaceuticals, Inc. insiders were filed in the last 90 days; 101 institutions reported holding it in 13F filings for Q2 2026, worth $36.1M in total; no superinvestor holds it.
13F holders, Q3 2023
Institutional positions in Inovio Pharmaceuticals, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 127
- −6 vs. Q2 2023
- Shares held
- 55.5M
- −16.2M (−22.6%) vs. Q2 2023
- Total value
- $21.6M
- −$10.4M (−32.5%) vs. Q2 2023
- New holders
- 16
- 24 more added
- Sold out
- 22
- 45 more reduced
2 institutions that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting INO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 101 | $36.1M |
| Q1 2026 | 99 | $54.6M |
| Q4 2025 | 101 | $57.5M |
| Q3 2025 | 99 | $48.4M |
| Q2 2025 | 103 | $20.7M |
| Q1 2025 | 108 | $22.2M |
| Q4 2024 | 105 | $24.4M |
| Q3 2024 | 98 | $49.5M |
| Q2 2024 | 96 | $65.1M |
| Q1 2024 | 89 | $56.4M |
| Q4 2023 | 116 | $25.7M |
| Q3 2023 | 127 | $21.6M |
| Q2 2023 | 135 | $32.1M |
| Q1 2023 | 177 | $99.8M |
| Q4 2022 | 186 | $198.5M |
| Q3 2022 | 183 | $200.0M |
| Q2 2022 | 185 | $196.2M |
| Q1 2022 | 201 | $330.4M |
| Q4 2021 | 209 | $428.9M |
| Q3 2021 | 213 | $554.9M |
| Q2 2021 | 211 | $683.1M |
| Q1 2021 | 219 | $693.7M |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Inovio Pharmaceuticals, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Prime Capital Investment Advisors, LLC | 138,972 | $54.1K | 0.00% | +94,637+213.5% | Added |
| Pathstone Family Office, LLC | 148,392 | $57.7K | 0.00% | +98,323+196.4% | Added |
| Price T Rowe Associates Inc | 150,000 | $59.0K | 0.00% | +68,500+84.0% | Added |
| Hennion & Walsh Asset Management, Inc. | 163,562 | $63.6K | 0.00% | −32,291−16.5% | Reduced |
| Susquehanna International Group, LLP | 167,669 | $65.2K | 0.00% | −589,744−77.9% | Reduced |
| FMR LLC | 185,334 | $72.1K | 0.00% | +160,024+632.3% | Added |
| Tudor Investment Corp Et Al | 226,021 | $87.9K | 0.00% | −327,463−59.2% | Reduced |
| Jane Street Group, LLC | 268,650 | $104.5K | 0.00% | −2,927,431−91.6% | Reduced |
| Gsa Capital Partners LLP | 296,948 | $116.0K | 0.01% | +296,948 | New |
| Verition Fund Management LLC | 300,045 | $116.7K | 0.00% | +75,045+33.4% | Added |
| Morgan Stanley | 304,237 | $118.3K | 0.00% | −72,440−19.2% | Reduced |
| Invesco Ltd. | 330,477 | $128.6K | 0.00% | +20,489+6.6% | Added |
| Bank of America Corp | 414,139 | $161.1K | 0.00% | −255,821−38.2% | Reduced |
| AQR Capital Management LLC | 449,706 | $174.9K | 0.00% | +449,706 | New |
| Acadian Asset Management LLC | 460,200 | $178.0K | 0.00% | +460,200 | New |
| Northern Trust Corp | 479,006 | $186.3K | 0.00% | +13,253+2.8% | Added |
| Green Alpha Advisors, LLC | 570,049 | $221.7K | 0.17% | +387,752+212.7% | Added |
| Two Sigma Investments, LP | 829,238 | $322.6K | 0.00% | −969,002−53.9% | Reduced |
| State Street Corp | 871,047 | $338.8K | 0.00% | −6,400−0.7% | Reduced |
| Jacobs Levy Equity Management, Inc | 1,149,974 | $447.3K | 0.00% | −997,345−46.4% | Reduced |
| GMT Capital Corp | 1,513,500 | $588.8K | 0.02% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 2,751,018 | $1.07M | 0.00% | −110,225−3.9% | Reduced |
| Millennium Management LLC | 4,578,455 | $1.78M | 0.00% | −761,798−14.3% | Reduced |
| Renaissance Technologies LLC | 4,889,500 | $1.90M | 0.00% | −546,781−10.1% | Reduced |
| D. E. Shaw & Co., Inc. | 5,518,837 | $2.15M | 0.00% | −2,083,296−27.4% | Reduced |
| BlackRock Inc. | 5,919,146 | $2.30M | 0.00% | −167,477−2.8% | Reduced |
| Vanguard Group Inc | 20,074,832 | $7.81M | 0.00% | +6,9490.0% | Added |
| Proequities, Inc. | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −633,613−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −500,624−100.0% | Sold out |
| UBS Asset Management Americas Inc | 0 | $0 | 0.00% | −151,318−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −244,500−100.0% | Sold out |
| CIBC Private Wealth Group, LLC | 0 | $0 | 0.00% | −119,110−100.0% | Sold out |
| Laurion Capital Management LP | 0 | $0 | 0.00% | −115,925−100.0% | Sold out |
| Schonfeld Strategic Advisors LLC | 0 | $0 | 0.00% | −107,687−100.0% | Sold out |
| Old Mission Capital LLC | 0 | $0 | 0.00% | −105,927−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −75,792−100.0% | Sold out |
| Allspring Global Investments Holdings, LLC | 0 | $0 | 0.00% | −66,536−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −64,715−100.0% | Sold out |
| Centiva Capital, LP | 0 | $0 | 0.00% | −54,405−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −47,902−100.0% | Sold out |
| CTC Alternative Strategies, Ltd. | 0 | $0 | 0.00% | −22,000−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −20,802−100.0% | Sold out |
| Horan Securities, Inc. | 0 | $0 | 0.00% | −1,702−100.0% | Sold out |
| New York State Common Retirement Fund | 0 | $0 | 0.00% | −1,626−100.0% | Sold out |
| Compass Wealth Management LLC | 0 | $0 | 0.00% | −170−100.0% | Sold out |
| Aspire Private Capital, LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| ICA Group Wealth Management, LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Avion Wealth | 0 | $0 | 0.00% | −747−100.0% | Sold out |
| Tiaa, FSB | – | – | – | – | Not filed |
| Kistler-Tiffany Companies, LLC | – | – | – | – | Not filed |